` WGRX (Wellgistics Health Inc) vs S&P 500 Comparison - Alpha Spread

W
WGRX
vs
S&P 500

Over the past 12 months, WGRX has underperformed S&P 500, delivering a return of -89% compared to the S&P 500's +14% growth.

Stocks Performance
WGRX vs S&P 500

Loading
WGRX
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
WGRX vs S&P 500

Loading
WGRX
S&P 500
Difference
www.alphaspread.com

Performance By Year
WGRX vs S&P 500

Loading
WGRX
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Wellgistics Health Inc vs Peers

S&P 500
WGRX
MSFT
ORCL
PLTR
SAP
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Wellgistics Health Inc
Glance View

Market Cap
43.6m USD
Industry
N/A

Wellgistics Health Inc is a US-based company operating in industry. The company is headquartered in Tampa, Florida. The company went IPO on 2025-02-21. Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. The company focuses on specialty medications and a community-based model offering home delivery services to patients. The company is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.

WGRX Intrinsic Value
Not Available
W
Back to Top